The novel bispecific diabody alpha CD40/alpha CD28 strengthens leukemic dendritic cell induced T cell reactivity.

Ilse Houtenbos, Saskia J. A. M. Santegoets, Theresia. M. Westers, Quinten Waisfisz, Sergey Kipriyanov, Fedor Denkers, Rik J. Scheper, Tanja D. de Gruijl, Gert Ossenkoppele, Arjan A. van Loosdrecht

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)1060A-1060A
JournalBlood
Volume108
Issue number11
Publication statusPublished - 16 Nov 2006

Cite this

Houtenbos, I., Santegoets, S. J. A. M., Westers, T. M., Waisfisz, Q., Kipriyanov, S., Denkers, F., ... van Loosdrecht, A. A. (2006). The novel bispecific diabody alpha CD40/alpha CD28 strengthens leukemic dendritic cell induced T cell reactivity. Blood, 108(11), 1060A-1060A.